Voronoi in a Nutshell
550,000
compound assay / year
4.5 > 1
average year of developing candidate
1st
small molecule drug patents
(patent cooperation treaty, Mar. 2025)
2
2 headquarters
Songdo, Boston
80%
research focused campus
researcher percentage of employees
6
3 research centers with 6 labs
In-vitro In-vivo AI
Transforming Science into Life
We turn cutting-edge science into life-saving therapies. At Voronoi, we challenge the toughest diseases with novel drugs that restore health and extend lives.
